Inappropriate prescribing of inhaled corticosteroids: Are they being prescribed for respiratory tract infections? a retrospective cohort study

Primary Care Respiratory Journal

Volumn 22, Issue 2, 2013, Pages 201-208

  Poulos, Leanne M ^a   Ampon, Rosario D ^a   Marks, Guy B ^a,b   Reddel, Helen K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Antibiotics; Inhaled corticosteroids; Lung diseases; Obstructive; Quality use of medicines; Respiratory tract infections

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL FUMARATE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CHRONIC RESPIRATORY TRACT DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEASONAL VARIATION; WINTER;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INFANT; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878487624     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2013.00036     Document Type: Article

References (37)

1. Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2007;(2).
2. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343(5):332-6. http://dx.doi.org/10.1056/NEJM200008033430504
3. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 2004;292(3):367-76. http://dx.doi.org/10.1001/jama.292.3.367
4. Yang IA, Clarke MS, Sim EHA, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;(7):CD002991.
5. Yang IA, Fong K, Sim EHA, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2008;(4).
6. National Asthma Council Australia. Asthma management handbook. Melbourne: National Asthma Council Australia, 2006.
7. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2011. Lutwyche, Queensland: Australian Lung Foundation, 2011.
8. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2011.
9. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global strategy for diagnosis, management and prevention of COPD. 2011.
10. NHS Information Centre for Health and Social Care. Prescriptions dispensed in the community: England. Statistics for 2000 to 2010. 2011.
11. Department of Health and Ageing. About the PBS. Canberra: Department of Health and Ageing, 2012.
12. Department of Health and Ageing. Pharmaceutical Benefits Scheme. Expenditure and prescriptions twelve months to 30 June 2011. Canberra: Department of Health and Ageing, 2012.
13. Australian Centre for Asthma Monitoring. Asthma in Australia 2011. AIHW Asthma Series no. 4. Cat. no. ACM 22. Canberra: Australian Institute of Health and Welfare, 2011.
14. Calverley PMA, Stockley RA, Seemungal TAR, et al. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest 2011;139(3):505-12. http://dx.doi.org/10.1378/chest.09-2992
15. Crim C, Calverley PMA, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34(3):641-7. http://dx.doi.org/10.1183/09031936.00193908
16. Gibson PG, Chang AB, Glasgow NJ, et al. CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. Med J Aust 2010;192(5):265-71.
17. Australian Bureau of Statistics. Socio-economic indices for areas (technical paper). Canberra: Australian Bureau of Statistics, 2006.
18. Australian Bureau of Statistics. Australian Standard Geographical Classification (ASGC). ABS Cat. no. 1216.0. Canberra: Australian Bureau of Statistics, 2010.
19. Druce J, Tran T, Kelly H, et al. Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol 2005;75(1):122-9. http://dx.doi.org/10.1002/jmv.20246
20. Johnston NW. The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. Proc Am Thorac Soc 2007;4(8):591-6. http://dx.doi.org/10.1513/pats.200706-064TH
21. Australian Institute of Health and Welfare. Australia's health 2010. Canberra: Australian Institute of Health and Welfare, 2010.
22. Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353(15):1555-63. http://dx.doi.org/10.1056/NEJMoa050824
23. Spiritus E. Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure. Am J Manag Care 2000;6(23 Suppl):S1216-21.
24. Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol 2007;120(5):1153-9. http://dx.doi.org/10.1016/j.jaci.2007.08.020
25. Penning-van Beest F, van Herk-Sukel M, Gale R, Lammers J-W, Herings R. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis. Respir Med 2011;105(2):259-65. http://dx.doi.org/10.1016/j.rmed.2010.07.007
26. Daniels JMA, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(2):150-7. http://dx.doi.org/10.1164/rccm.200906-0837OC
27. Glauber JH, Fuhlbrigge AL, Finkelstein JA, Homer CJ, Weiss ST. Relationship between asthma medication and antibiotic use. Chest 2001;120(5):1485-92. http://dx.doi.org/10.1378/chest.120.5.1485
28. Dennis SM, Zwar NA, Marks GB. Diagnosing asthma in adults in primary care: a qualitative study of Australian GPs' experiences. Prim Care Respir J 2010;19(1):52-6. http://dx.doi.org/10.4104/pcrj.2009.00046
29. Johnston NW, Sears MR. Asthma exacerbations. 1: Epidemiology. Thorax 2006;61(8):722-8. http://dx.doi.org/10.1136/thx.2005.045161
30. Sears MR, Johnston NW. Understanding the September asthma epidemic. J Allergy Clin Immunol 2007;120(3):526-9. http://dx.doi.org/10.1016/j.jaci.2007.05.047
31. Lister S, Sheppeard V, Morgan G, Corbett S, Kaldor J, Henry R. February asthma outbreaks in NSW: a case control study. Aust NZ J Public Health 2001;25(6):514-19. http://dx.doi.org/10.1111/j.1467-842X.2001.tb00315.x
32. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;115(1):132-8. http://dx.doi.org/10.1016/j.jaci.2004.09.025
33. Tovey ER, Rawlinson WD. A modern miasma hypothesis and back-to-school asthma exacerbations. Med Hypotheses 2011;76(1):113-6. http://dx.doi.org/10.1016/j.mehy.2010.08.045
34. Charles J, Pan Y, Britt H. Trends in childhood illness and treatment in Australian general practice, 1971-2001. Med J Aust 2004;180:216-19.
35. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006;15(1):20-34. http://dx.doi.org/10.1016/j.pcrj.2005.10.004
36. Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010;36(3):601-07. http://dx.doi.org/10.1183/09031936.00163309
37. National Prescribing Service. Respiratory tract infections: symptomatic management pad and patient counselling tool. Sydney: National Prescribing Service, 2012.